- Home
- DRIO vs VANI Comparison
DRIO vs VANI Comparison
Compare DRIO & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRIO | VANI |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.1M | 91.9M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | DRIO | VANI |
|---|---|---|
| Price | $10.76 | $1.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $50.00 | $4.00 |
| AVG Volume (30 Days) | 10.5K | ★ 453.6K |
| Earning Date | 03-09-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,732,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.64 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.29 | N/A |
| 52 Week Low | $5.94 | $0.91 |
| 52 Week High | $17.74 | $1.92 |
Technical Indicators
Market Signals| Indicator | DRIO | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 43.83 | 50.27 |
| Support Level | $9.94 | $1.30 |
| Resistance Level | $11.13 | $1.55 |
| Average True Range (ATR) | 0.57 | 0.11 |
| MACD | -0.12 | 0.01 |
| Stochastic Oscillator | 32.22 | 47.20 |
Price Performance
Historical ComparisonAbout DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.